Literature DB >> 11122232

Pathogenic roles of eosinophils in guinea-pig contact sensitivity: regulation of dermal eosinophilia with remotely administered IL-5.

T Satoh1, H Yokozeki, K Nishioka.   

Abstract

Eosinophils have a variety of functions. Although increasing evidence links the presence of eosinophils to airway damage, studies have not examined in detail if, and how, eosinophils affect skin inflammation. The purpose of this study was to determine whether eosinophil infiltration augments the contact sensitivity reaction in vivo. Guinea-pigs were sensitized with 2, 4-dinitrochlorobenzene and challenged on the dorsal skin or on the right ear lobe. The number of eosinophils and macroscopic changes of the skin lesion in the presence or absence of human recombinant IL-5 (rIL-5) administered at the remote site was assessed. The reaction on the dorsal skin was acutely eczematous with considerable basophil infiltration. In contrast, eosinophils had extensively infiltrated the right ear lobe and major basic protein was deposited in the dermis. A subcutaneous injection of rIL-5 (10 pmol/kg) at the remote site (left ear lobe) 12 h after challenge induced transient blood eosinophilia and enhanced eosinophil accumulation in the challenged ear lobe. These changes were accompanied by increased ear swelling and severe erythema. In contrast, eosinophil infiltration was significantly inhibited by rIL-5 administered at the time of challenge. Ear thickness, as well as the erythema and oedema, were also reduced. These data suggest that marked eosinophil infiltration enhances skin inflammation in allergic contact dermatitis. Moreover, locally administered IL-5 functions remotely by controlling eosinophil recruitment into the skin. The guinea-pig model of contact sensitivity may be useful for evaluating therapies and pharmaceuticals targeted at eosinophil infiltration.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11122232      PMCID: PMC1905784          DOI: 10.1046/j.1365-2249.2000.01355.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  40 in total

1.  Selective inhibition of IL-5 receptor alpha-chain gene transcription by IL-5, IL-3, and granulocyte-macrophage colony-stimulating factor in human blood eosinophils.

Authors:  P Wang; P Wu; B Cheewatrakoolpong; J G Myers; R W Egan; M M Billah
Journal:  J Immunol       Date:  1998-05-01       Impact factor: 5.422

2.  Acidic polyamino acids inhibit human eosinophil granule major basic protein toxicity. Evidence of a functional role for ProMBP.

Authors:  R L Barker; R H Gundel; G J Gleich; J L Checkel; D A Loegering; L R Pease; K J Hamann
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

3.  Basophils in allergen-induced patch test sites in atopic dermatitis.

Authors:  E B Mitchell; J Crow; M D Chapman; S S Jouhal; F M Pope; T A Platts-Mills
Journal:  Lancet       Date:  1982-01-16       Impact factor: 79.321

4.  Deposits of eosinophil granule proteins in cardiac tissues of patients with eosinophilic endomyocardial disease.

Authors:  P C Tai; S J Ackerman; C J Spry; S Dunnette; E G Olsen; G J Gleich
Journal:  Lancet       Date:  1987-03-21       Impact factor: 79.321

5.  Effects of IL-5, granulocyte/macrophage colony-stimulating factor (GM-CSF) and IL-3 on the survival of human blood eosinophils in vitro.

Authors:  P C Tai; L Sun; C J Spry
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

6.  Human ecalectin, a variant of human galectin-9, is a novel eosinophil chemoattractant produced by T lymphocytes.

Authors:  R Matsumoto; H Matsumoto; M Seki; M Hata; Y Asano; S Kanegasaki; R L Stevens; M Hirashima
Journal:  J Biol Chem       Date:  1998-07-03       Impact factor: 5.157

7.  Human eosinophil hematopoiesis studied in vitro by means of murine eosinophil differentiation factor (IL5): production of functionally active eosinophils from normal human bone marrow.

Authors:  E J Clutterbuck; C J Sanderson
Journal:  Blood       Date:  1988-03       Impact factor: 22.113

8.  Recombinant human interleukin 5 is a selective eosinophil chemoattractant.

Authors:  J M Wang; A Rambaldi; A Biondi; Z G Chen; C J Sanderson; A Mantovani
Journal:  Eur J Immunol       Date:  1989-04       Impact factor: 5.532

9.  Activation of basophil and mast cell histamine release by eosinophil granule major basic protein.

Authors:  M C O'Donnell; S J Ackerman; G J Gleich; L L Thomas
Journal:  J Exp Med       Date:  1983-06-01       Impact factor: 14.307

10.  Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor.

Authors:  Y Yamaguchi; Y Hayashi; Y Sugama; Y Miura; T Kasahara; S Kitamura; M Torisu; S Mita; A Tominaga; K Takatsu
Journal:  J Exp Med       Date:  1988-05-01       Impact factor: 14.307

View more
  2 in total

1.  Synthesis of {alpha}(1,3) fucosyltransferases IV- and VII-dependent eosinophil selectin ligand and recruitment to the skin.

Authors:  Takahiro Satoh; Yasumasa Kanai; Ming-Hua Wu; Hiroo Yokozeki; Reiji Kannagi; John B Lowe; Kiyoshi Nishioka
Journal:  Am J Pathol       Date:  2005-09       Impact factor: 4.307

2.  Indomethacin inhibits eosinophil migration to prostaglandin D2 : therapeutic potential of CRTH2 desensitization for eosinophilic pustular folliculitis.

Authors:  Naoko Kataoka; Takahiro Satoh; Aiko Hirai; Kazumi Saeki; Hiroo Yokozeki
Journal:  Immunology       Date:  2013-09       Impact factor: 7.397

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.